Table I. Clinical data for patients with acute Kawasaki disease (KD):
Patient Age/Sex Ethnicity Duration of illness Cause of death Treatment
KD 1 4 Months/ M Caucasian Unknown Myocardial infarct None
KD 2 3 Months/ F Caucasian 2 Weeks Myocardial infarct None
KD 3 22 Months/ M Caucasian Unknown Ruptured CAA None
KD 4 10 Months/ F Black 4 Weeks Myocardial infarct Aspirin
KD 5 6 Months/M Caucasian 3 Months Myocardial infarct* IVGG, OHT
KD 6 8 Months/ F Unknown 3 Weeks Ruptured CAA None
KD 7 24 Months/ M Caucasian 5 Weeks Myocardial infarct IVGG/aspirin/
corticosteroids
KD 8 11 Months/ M Caucasian 15 Days Ruptured CAA None
KD 9 4 Months/ M Hispanic 4 Weeks Congestive failure None
KD 10 4 Months/ F Caucasian 8 Weeks Myocardial infarct IVGG/aspirin/
methylprednisolone/
methotrexate.
KD 11 4 Months/ M Caucasian 3 Weeks Myocarditis/arrythmia IVGG/aspirin
Note.CAA, Coronary artery aneurysm; IVGG, Intravenous gammaglobulin;OHT, orthotopic heart transplant.
*patient survived after OHT
Table II. Clinical data for control patients:
Patient Age/Sex Ethnicity Cause of death
A 6 Weeks/ M Caucasian NEC
B 8 Months/ M Caucasian CNS malformation
C 3 Years/ M Unknown Bacterial meningitis
D 8 Months/ F Caucasian CNS tumor
E 15 Years/ M Unknown Aspiration pneumonia
F 4 Months/ F Unknown Gram negative sepsis
G 13 Days/ F Hispanic Gram negative sepsis
Note. NEC, necrotizing enterocolitis; CNS, central nervous system.